where to next?, page-716

Don't you think that the Cann Group would be in the position to do better as they work with Vic Dept of Health on this. AusCann has nothing going on now and does not even say anything about getting clinical trial arrangements set up. No one would buy the product (if available) unless it has been trialled. Perhaps not the science but the quality, the purity ... Also it will be in solid form so it's a new thing that no one knows if it can keep the active ingredient preserved. What I worry about is that this thing will face all the common pain killers on the market and does not provide a significant benefit. SAS is only ever a very limited access. It will barely generate any income at all. The track record of AusCann will be seen in time. At the current rate I am pessimistic about the chance AusCann will have a product even for ASA purpose.